Heayoung Shin
Vice President, Medical Affairs
Professional Overview
Heayoung Shin is an accomplished pharmaceutical executive with over 15 years of experience leading medical affairs and research initiatives in the hematology and oncology space. As the Vice President of Medical Affairs at Gamida Cell Ltd., she is responsible for driving the company's medical strategy, overseeing key opinion leader engagement, and supporting the successful global commercialization of novel cell therapies.
Experience Summary
Current Role
As Vice President of Medical Affairs at Gamida Cell, Heayoung is instrumental in guiding the company's medical affairs function, aligning it with the overall corporate strategy. She leads a team of medical science liaisons and oversees the development and implementation of medical affairs initiatives that support the clinical and commercial success of Gamida Cell's pipeline products. Under her leadership, the medical affairs team has successfully facilitated clinical trial enrollment, strengthened relationships with key opinion leaders, and enhanced medical education efforts to better serve the needs of healthcare providers and patients.
Career Progression
Prior to her current role, Heayoung held several senior positions in medical affairs and research collaborations at leading biopharmaceutical companies, including Bristol Myers Squibb and Incyte Corporation. She has a proven track record of driving strategic medical affairs initiatives, managing high-performing teams, and fostering productive partnerships with academic and clinical institutions. Heayoung's extensive experience in the hematology and oncology space has allowed her to make significant contributions to the development and commercialization of innovative therapies that have positively impacted patient outcomes.
Academic Background
Heayoung holds a Doctor of Pharmacy (Pharm.D.) degree from the University of California, San Francisco, where she also completed a post-doctoral fellowship in Hematology/Oncology. Her educational background, combined with her deep industry expertise, has positioned her as a respected thought leader in the medical affairs community.
Areas of Expertise
- Medical affairs strategy and operations
- Key opinion leader engagement and advocacy
- Clinical trial design and execution
- Medical education and publications
- Cross-functional collaboration and team management
- Strategic partnerships and business development
Professional Impact
Throughout her career, Heayoung has played a pivotal role in the successful development and commercialization of several hematology and oncology therapies. At Bristol Myers Squibb, she led the medical affairs team that supported the launch of a novel immunotherapy for leukemia, which significantly improved patient outcomes. At Incyte Corporation, she spearheaded the establishment of a robust medical affairs infrastructure that enhanced the company's global medical presence and bolstered its research collaborations.
Conclusion
Heayoung Shin's extensive experience, strategic vision, and strong leadership skills make her a valuable asset to Gamida Cell as it continues to advance its pipeline of innovative cell therapies. Her deep understanding of the hematology and oncology landscape, coupled with her proven track record of driving medical affairs initiatives, positions her to play a pivotal role in the company's future success and the continued advancement of treatments for patients in need.
